HPV Vaccine for Men

20-45 years of age | Males

To evaluate the safety and effectiveness of the 9vHPV vaccine in the prevention of oral persistent infection caused by HPV subtypes.

Eligibility

• Must not have ever received a prior HPV vaccine
• Must not have received any other vaccines within 14-21 days prior to first study visit
• Must be otherwise healthy

Trial Duration

10 visits over ~ 42 months

Compensation

$200 for completion of Visit 1, $100 for all other completed study visits